speb/financial-data huggingface dataset:
SMRT income_statement (annual, 2024-12-31) — +Total Revenue: 174885000.00
SMRT balance_sheet (annual, 2024-12-31) — Accounts Payable: 8716000.00
SMRT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 59299000.00
SMRT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -3171000.00
SMRT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 637361000.00
SMRT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2797000.00
SMRT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 2250000.00
SMRT income_statement (annual, 2024-12-31) — Basic Average Shares: 199181000.00
SMRT income_statement (annual, 2024-12-31) — Basic EPS: -0.17
SMRT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 215709000.00
SMRT balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 815000.00
SMRT cash_flow (annual, 2024-12-31) — Capital Expenditure: -7599000.00
SMRT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -5832000.00
SMRT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7021000.00
SMRT balance_sheet (annual, 2024-12-31) — Capital Stock: 19000.00
SMRT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 142482000.00
SMRT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 142482000.00
SMRT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -32962000.00
SMRT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -7599000.00
SMRT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -32913000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Account Payable: -6402000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -658000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Inventory: -1279000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1468000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -24252000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Payable: -6402000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -7060000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 4541000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Receivables: 1101000.00
SMRT cash_flow (annual, 2024-12-31) — Change In Working Capital: -28417000.00
SMRT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 1101000.00
SMRT cash_flow (annual, 2024-12-31) — Changes In Cash: -73474000.00
SMRT balance_sheet (annual, 2024-12-31) — Common Stock: 19000.00
SMRT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 289435000.00
SMRT cash_flow (annual, 2024-12-31) — Common Stock Payments: -28566000.00
SMRT income_statement (annual, 2024-12-31) — Cost Of Revenue: 114547000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 14812000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Assets: 257650000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 8727000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 35071000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 35071000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Liabilities: 71032000.00
SMRT balance_sheet (annual, 2024-12-31) — Current Provisions: 1077000.00
SMRT cash_flow (annual, 2024-12-31) — Deferred Income Tax: 0.00
SMRT cash_flow (annual, 2024-12-31) — Deferred Tax: 0.00
SMRT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 6495000.00
SMRT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 6495000.00
SMRT income_statement (annual, 2024-12-31) — Diluted Average Shares: 199181000.00
SMRT income_statement (annual, 2024-12-31) — Diluted EPS: -0.17
SMRT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -33643000.00
SMRT income_statement (annual, 2024-12-31) — EBIT: -32976000.00
SMRT income_statement (annual, 2024-12-31) — EBITDA: -26481000.00
SMRT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 247000.00
SMRT cash_flow (annual, 2024-12-31) — End Cash Position: 142482000.00
SMRT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -32962000.00
SMRT balance_sheet (annual, 2024-12-31) — Finished Goods: 34876000.00
SMRT cash_flow (annual, 2024-12-31) — Free Cash Flow: -40512000.00
SMRT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -98000.00
SMRT income_statement (annual, 2024-12-31) — General And Administrative Expense: 54295000.00
SMRT balance_sheet (annual, 2024-12-31) — Goodwill: 117268000.00
SMRT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 150106000.00
SMRT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 62096000.00
SMRT balance_sheet (annual, 2024-12-31) — Gross PPE: 9430000.00
SMRT income_statement (annual, 2024-12-31) — Gross Profit: 60338000.00
SMRT income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
SMRT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 236000.00
SMRT income_statement (annual, 2024-12-31) — Interest Expense: 400000.00
SMRT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 400000.00
SMRT income_statement (annual, 2024-12-31) — Interest Income: 8642000.00
SMRT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 8642000.00
SMRT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 259000.00
SMRT balance_sheet (annual, 2024-12-31) — Inventory: 35261000.00
SMRT balance_sheet (annual, 2024-12-31) — Invested Capital: 289435000.00
SMRT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -7599000.00
SMRT balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
SMRT balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
SMRT balance_sheet (annual, 2024-12-31) — Leases: 2185000.00
SMRT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 7021000.00
SMRT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7021000.00
SMRT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2622000.00
SMRT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
SMRT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -28566000.00
SMRT income_statement (annual, 2024-12-31) — Net Income: -33643000.00
SMRT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -33643000.00
SMRT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -33643000.00
SMRT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -33643000.00
SMRT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -33643000.00
SMRT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -33643000.00
SMRT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -33643000.00
SMRT income_statement (annual, 2024-12-31) — Net Interest Income: 8242000.00
SMRT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 8242000.00
SMRT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -3486000.00
SMRT balance_sheet (annual, 2024-12-31) — Net PPE: 6259000.00
SMRT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1767000.00
SMRT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 139329000.00
SMRT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 3073000.00
SMRT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 52588000.00
SMRT balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 52588000.00
SMRT income_statement (annual, 2024-12-31) — Normalized EBITDA: -26481000.00
SMRT income_statement (annual, 2024-12-31) — Normalized Income: -33643000.00
SMRT cash_flow (annual, 2024-12-31) — Operating Cash Flow: -32913000.00
SMRT income_statement (annual, 2024-12-31) — Operating Income: -41772000.00
SMRT income_statement (annual, 2024-12-31) — Operating Revenue: 174885000.00
SMRT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 192049000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Current Assets: 4014000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 3107000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -98000.00
SMRT income_statement (annual, 2024-12-31) — Other Gand A: 54295000.00
SMRT income_statement (annual, 2024-12-31) — Other Income Expense: 154000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 32838000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Investments: 0.00
SMRT balance_sheet (quarterly, 2024-12-31) — Other Investments: 0.00
SMRT cash_flow (annual, 2024-12-31) — Other Non Cash Items: 5584000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 3088000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 100000.00
SMRT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 154000.00
SMRT balance_sheet (annual, 2024-12-31) — Other Properties: 3808000.00
SMRT balance_sheet (annual, 2024-12-31) — Payables: 8716000.00
SMRT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 23528000.00
SMRT balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8249000.00
SMRT balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 7867000.00
SMRT income_statement (annual, 2024-12-31) — Pretax Income: -33376000.00
SMRT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: -910000.00
SMRT balance_sheet (annual, 2024-12-31) — Properties: 0.00
SMRT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 2747000.00
SMRT cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
SMRT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1767000.00
SMRT balance_sheet (annual, 2024-12-31) — Raw Materials: 385000.00
SMRT balance_sheet (annual, 2024-12-31) — Receivables: 59299000.00
SMRT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 114547000.00
SMRT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 6495000.00
SMRT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -28566000.00
SMRT income_statement (annual, 2024-12-31) — Research And Development: 29369000.00
SMRT balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
SMRT balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
SMRT balance_sheet (annual, 2024-12-31) — Retained Earnings: -347847000.00
SMRT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 18446000.00
SMRT income_statement (annual, 2024-12-31) — Selling General And Administration: 72741000.00
SMRT balance_sheet (annual, 2024-12-31) — Share Issued: 192049000.00
SMRT income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
SMRT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 12071000.00
SMRT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 289435000.00
SMRT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 139329000.00
SMRT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SMRT income_statement (annual, 2024-12-31) — Tax Provision: 267000.00
SMRT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
SMRT balance_sheet (annual, 2024-12-31) — Total Assets: 420176000.00
SMRT balance_sheet (annual, 2024-12-31) — Total Capitalization: 289435000.00
SMRT balance_sheet (annual, 2024-12-31) — Total Debt: 7021000.00
SMRT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 289435000.00
SMRT income_statement (annual, 2024-12-31) — Total Expenses: 216657000.00
SMRT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 130741000.00
SMRT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 162526000.00
SMRT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 59709000.00
SMRT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -41772000.00
SMRT income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
SMRT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SMRT balance_sheet (annual, 2024-12-31) — Working Capital: 186618000.00
SMRT income_statement (quarterly, 2025-03-31) — +Operating Expense: 29922000.00
SMRT income_statement (quarterly, 2025-03-31) — +Total Revenue: 41344000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 12090000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 49859000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3360000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 639894000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2964000.00
SMRT cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 24929000.00
SMRT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 192419000.00
SMRT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.21
SMRT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 142482000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 835000.00
SMRT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3469000.00
SMRT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1289000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6722000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 125600000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 125600000.00
SMRT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1505000.00
SMRT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3469000.00
SMRT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -12169000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2540000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2615000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Inventory: 1885000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -185000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -13230000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Payable: 2540000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -75000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -380000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 9424000.00
SMRT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2561000.00
SMRT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 9424000.00
SMRT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -17143000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Common Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 250670000.00
SMRT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1202000.00
SMRT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 27782000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 16885000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Assets: 227863000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 7109000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 38887000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 38887000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 75873000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Current Provisions: 881000.00
SMRT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1943000.00
SMRT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1943000.00
SMRT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 192419000.00
SMRT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.21
SMRT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — EBIT: -39973000.00
SMRT income_statement (quarterly, 2025-03-31) — EBITDA: -38030000.00
SMRT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 261000.00
SMRT cash_flow (quarterly, 2025-03-31) — End Cash Position: 125600000.00
SMRT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1505000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Finished Goods: 32804000.00
SMRT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -15638000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -10000.00
SMRT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16894000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Goodwill: 92339000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 124581000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 52823000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 12177000.00
SMRT income_statement (quarterly, 2025-03-31) — Gross Profit: 13562000.00
SMRT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 126000.00
SMRT income_statement (quarterly, 2025-03-31) — Interest Expense: 103000.00
SMRT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 103000.00
SMRT income_statement (quarterly, 2025-03-31) — Interest Income: 1303000.00
SMRT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1303000.00
SMRT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 70000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Inventory: 33189000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 250670000.00
SMRT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3469000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Leases: 5125000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 6722000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6722000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2705000.00
SMRT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1202000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Income: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -40184000.00
SMRT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -40184000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Interest Income: 1200000.00
SMRT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1200000.00
SMRT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -478000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Net PPE: 8817000.00
SMRT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2180000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 126089000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1851000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 32704000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 32704000.00
SMRT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -13101000.00
SMRT income_statement (quarterly, 2025-03-31) — Normalized Income: -20490090.00
SMRT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -12169000.00
SMRT income_statement (quarterly, 2025-03-31) — Operating Income: -16360000.00
SMRT income_statement (quarterly, 2025-03-31) — Operating Revenue: 41344000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 191749000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3158000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1995000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -10000.00
SMRT income_statement (quarterly, 2025-03-31) — Other Gand A: 16894000.00
SMRT income_statement (quarterly, 2025-03-31) — Other Income Expense: -24916000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 32242000.00
SMRT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 333000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2953000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 96000.00
SMRT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 13000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Other Properties: 3512000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Payables: 12090000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 28975000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5135000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 8948000.00
SMRT income_statement (quarterly, 2025-03-31) — Pretax Income: -40076000.00
SMRT cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 175000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SMRT cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 535000.00
SMRT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2180000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Raw Materials: 385000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Receivables: 49859000.00
SMRT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 27782000.00
SMRT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1943000.00
SMRT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1202000.00
SMRT income_statement (quarterly, 2025-03-31) — Research And Development: 8258000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -389233000.00
SMRT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 4770000.00
SMRT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 21664000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Share Issued: 191749000.00
SMRT income_statement (quarterly, 2025-03-31) — Special Income Charges: -24929000.00
SMRT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2836000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 250670000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 126089000.00
SMRT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -5235090.00
SMRT income_statement (quarterly, 2025-03-31) — Tax Provision: 108000.00
SMRT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
SMRT balance_sheet (quarterly, 2025-03-31) — Total Assets: 366065000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 250670000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Total Debt: 6722000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 250670000.00
SMRT income_statement (quarterly, 2025-03-31) — Total Expenses: 57704000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 115395000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 138202000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 39522000.00
SMRT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -41289000.00
SMRT income_statement (quarterly, 2025-03-31) — Total Unusual Items: -24929000.00
SMRT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -24929000.00
SMRT balance_sheet (quarterly, 2025-03-31) — Working Capital: 151990000.00
SMRT income_statement (quarterly, 2025-03-31) — Write Off: 24929000.00
SMRT income_statement (quarterly, 2025-06-30) — +Operating Expense: 24353000.00
SMRT income_statement (quarterly, 2025-06-30) — +Total Revenue: 38308000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 11664000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 58571000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -3090000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 642010000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2938000.00
SMRT cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
SMRT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 188755000.00
SMRT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.06
SMRT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 125600000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 879000.00
SMRT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2381000.00
SMRT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1099000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 6415000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 105044000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 105044000.00
SMRT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3761000.00
SMRT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2381000.00
SMRT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -14930000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 374000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 5199000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Inventory: -507000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -13000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -2973000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Payable: 374000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 5573000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -2441000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -8527000.00
SMRT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -8888000.00
SMRT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -8527000.00
SMRT cash_flow (quarterly, 2025-06-30) — Changes In Cash: -21072000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Common Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 238849000.00
SMRT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -3716000.00
SMRT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 25640000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 20835000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Assets: 217543000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 5782000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 37807000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 37807000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 80059000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Current Provisions: 856000.00
SMRT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2066000.00
SMRT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2066000.00
SMRT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 188755000.00
SMRT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.06
SMRT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — EBIT: -11685000.00
SMRT income_statement (quarterly, 2025-06-30) — EBITDA: -9619000.00
SMRT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 516000.00
SMRT cash_flow (quarterly, 2025-06-30) — End Cash Position: 105044000.00
SMRT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3761000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Finished Goods: 32967000.00
SMRT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -17311000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 629000.00
SMRT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 11513000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Goodwill: 92339000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 123771000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 61509000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 12033000.00
SMRT income_statement (quarterly, 2025-06-30) — Gross Profit: 12668000.00
SMRT income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
SMRT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 173000.00
SMRT income_statement (quarterly, 2025-06-30) — Interest Income: 1012000.00
SMRT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1012000.00
SMRT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 55000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Inventory: 33352000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 238849000.00
SMRT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2381000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Leases: 5169000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6415000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6415000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2625000.00
SMRT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -3716000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Income: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -10860000.00
SMRT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -10860000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Interest Income: 1012000.00
SMRT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1012000.00
SMRT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -45000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Net PPE: 8943000.00
SMRT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1282000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 115078000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 910000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 28550000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 28550000.00
SMRT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -9619000.00
SMRT income_statement (quarterly, 2025-06-30) — Normalized Income: -10860000.00
SMRT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -14930000.00
SMRT income_statement (quarterly, 2025-06-30) — Operating Income: -11685000.00
SMRT income_statement (quarterly, 2025-06-30) — Operating Revenue: 38308000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 188064000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7035000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2063000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 629000.00
SMRT income_statement (quarterly, 2025-06-30) — Other Gand A: 11513000.00
SMRT income_statement (quarterly, 2025-06-30) — Other Income Expense: -220000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 31432000.00
SMRT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -106000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2802000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 96000.00
SMRT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -220000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Other Properties: 3360000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Payables: 11664000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 32499000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6834000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 7759000.00
SMRT income_statement (quarterly, 2025-06-30) — Pretax Income: -10893000.00
SMRT cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
SMRT balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
SMRT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 697000.00
SMRT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1282000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Raw Materials: 385000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Receivables: 58571000.00
SMRT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 25640000.00
SMRT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2066000.00
SMRT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -3716000.00
SMRT income_statement (quarterly, 2025-06-30) — Research And Development: 6465000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -403809000.00
SMRT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 6375000.00
SMRT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 17888000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Share Issued: 188064000.00
SMRT income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
SMRT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2161000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 238849000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 115078000.00
SMRT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SMRT income_statement (quarterly, 2025-06-30) — Tax Provision: -33000.00
SMRT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Assets: 353969000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 238849000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Debt: 6415000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 238849000.00
SMRT income_statement (quarterly, 2025-06-30) — Total Expenses: 49993000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 115120000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 136426000.00
SMRT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 35061000.00
SMRT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -11685000.00
SMRT income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
SMRT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
SMRT balance_sheet (quarterly, 2025-06-30) — Working Capital: 137484000.00
SMRT income_statement (quarterly, 2025-09-30) — +Operating Expense: 16596000.00
SMRT income_statement (quarterly, 2025-09-30) — +Total Revenue: 36202000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 10811000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 52195000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3392000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 643830000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2468000.00
SMRT cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
SMRT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 188376000.00
SMRT income_statement (quarterly, 2025-09-30) — Basic EPS: -0.03
SMRT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 105044000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 949000.00
SMRT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1091000.00
SMRT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1001000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 6105000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 100022000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 100022000.00
SMRT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1730000.00
SMRT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1091000.00
SMRT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2133000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -964000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -3715000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Inventory: 2012000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -104000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -5637000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Payable: -964000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -4679000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1796000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 6964000.00
SMRT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -3240000.00
SMRT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 6964000.00
SMRT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -4954000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Common Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 234412000.00
SMRT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
SMRT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 26633000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 15909000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Assets: 201465000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 4356000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 36195000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 36195000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 72623000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Current Provisions: 515000.00
SMRT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2201000.00
SMRT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2201000.00
SMRT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 188376000.00
SMRT income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.03
SMRT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — EBIT: -7027000.00
SMRT income_statement (quarterly, 2025-09-30) — EBITDA: -4826000.00
SMRT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -68000.00
SMRT cash_flow (quarterly, 2025-09-30) — End Cash Position: 100022000.00
SMRT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1730000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Finished Goods: 27702000.00
SMRT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3224000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 623000.00
SMRT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6093000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Goodwill: 92339000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 122900000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 54663000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 11980000.00
SMRT income_statement (quarterly, 2025-09-30) — Gross Profit: 9569000.00
SMRT income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
SMRT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 41000.00
SMRT income_statement (quarterly, 2025-09-30) — Interest Income: 891000.00
SMRT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 891000.00
SMRT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 3000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Inventory: 28087000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 234412000.00
SMRT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1091000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Leases: 5176000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6105000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6105000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 2645000.00
SMRT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
SMRT income_statement (quarterly, 2025-09-30) — Net Income: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -6270000.00
SMRT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -6270000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Interest Income: 891000.00
SMRT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 891000.00
SMRT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1840000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Net PPE: 8588000.00
SMRT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -90000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 111512000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 374000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 22561000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 22561000.00
SMRT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -4826000.00
SMRT income_statement (quarterly, 2025-09-30) — Normalized Income: -6270000.00
SMRT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2133000.00
SMRT income_statement (quarterly, 2025-09-30) — Operating Income: -7027000.00
SMRT income_statement (quarterly, 2025-09-30) — Operating Revenue: 36202000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 189196000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 10271000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2476000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 623000.00
SMRT income_statement (quarterly, 2025-09-30) — Other Gand A: 6093000.00
SMRT income_statement (quarterly, 2025-09-30) — Other Income Expense: -78000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 30561000.00
SMRT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 182000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2470000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 96000.00
SMRT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -78000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Other Properties: 3210000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Payables: 10811000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 26720000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 6717000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 6534000.00
SMRT income_statement (quarterly, 2025-09-30) — Pretax Income: -6214000.00
SMRT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 110000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
SMRT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 2910000.00
SMRT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -90000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Raw Materials: 385000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Receivables: 52195000.00
SMRT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 26633000.00
SMRT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2201000.00
SMRT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
SMRT income_statement (quarterly, 2025-09-30) — Research And Development: 6149000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -410060000.00
SMRT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4354000.00
SMRT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10447000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Share Issued: 189196000.00
SMRT income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
SMRT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2084000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 234412000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 111512000.00
SMRT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SMRT income_statement (quarterly, 2025-09-30) — Tax Provision: 56000.00
SMRT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
SMRT balance_sheet (quarterly, 2025-09-30) — Total Assets: 335797000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 234412000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Total Debt: 6105000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 234412000.00
SMRT income_statement (quarterly, 2025-09-30) — Total Expenses: 43229000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 101385000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 134332000.00
SMRT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28762000.00
SMRT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -7027000.00
SMRT income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00